The FOXP3(+) Pro-inflammatory T cell: A Potential Therapeutic Target in Crohn's Disease. Kosinsky RL, Gonzalez MM, Saul D, Barros LL, et al. Gastroenterology 2024 Jan 9:S0016-5085(24)00009.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kosinsky RL, Gonzalez MM, Saul D, Barros LL, et al. The FOXP3(+) Pro-inflammatory T cell: A Potential Therapeutic Target in Crohn's Disease. Gastroenterology 2024 Jan 9:S0016-5085(24)00009.
PMID: 38211712